TY - JOUR
T1 - Catering to chondrocytes
AU - Evans, Christopher H.
N1 - Funding Information:
C.H.E.'s research is funded by the U.S. Department of Defense (W81XWH-16-1-0540) and the Michael and Mary Sue Shannon Philanthropic Fund.
Publisher Copyright:
Copyright © 2018, American Association for the Advancement of Science
PY - 2018/11/28
Y1 - 2018/11/28
N2 - In 1743, William Hunter complained that “ulcerated cartilage is universally allowed to be a very troublesome disease…that, when destroyed, it is never recovered” (1). Fast forward 275 years and nothing much has changed: Cartilage still does not regenerate and osteoarthritis (OA), the main cause of cartilage degeneration, is rampant. In this issue of Science TranslationalMedicine, Geiger etal. (2) describe a novel technology that offers considerable promise for reversing this miserable state of affairs.
AB - In 1743, William Hunter complained that “ulcerated cartilage is universally allowed to be a very troublesome disease…that, when destroyed, it is never recovered” (1). Fast forward 275 years and nothing much has changed: Cartilage still does not regenerate and osteoarthritis (OA), the main cause of cartilage degeneration, is rampant. In this issue of Science TranslationalMedicine, Geiger etal. (2) describe a novel technology that offers considerable promise for reversing this miserable state of affairs.
UR - http://www.scopus.com/inward/record.url?scp=85057362191&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85057362191&partnerID=8YFLogxK
U2 - 10.1126/scitranslmed.aav7043
DO - 10.1126/scitranslmed.aav7043
M3 - Article
C2 - 30487250
AN - SCOPUS:85057362191
SN - 1946-6234
VL - 10
JO - Science translational medicine
JF - Science translational medicine
IS - 469
M1 - eaav7043
ER -